NeuralInk
Focus: NeuralInk develops neural implant devices and brain-computer interface (BCI) systems focused on restoring motor function in spinal cord injury patients. The company is headquartered in Fremont, CA and is actively hiring across 80 open roles.
Profile data last refreshed 11h ago · AI intelligence enriched 1w ago
Open Jobs
79+6 this month
Growing — net +6 jobs in 30d
15 jobs added vs 9 removed. Steady team buildout.
Should You Work at NeuralInk?
AI assessmentNeuralInk is a high-risk, high-upside early-stage medical device play best suited for engineers and translational scientists willing to bet on breakthrough BCI technology and company survival.
Why Work Here
- Ground-floor opportunity in an emerging BCI/neural implants space with 7 active clinical programs targeting high-impact indications like tetraplegia
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
7 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Eye Tracker
Spinal Cord InjuryClinical Trials (1)
NCT07407725Clinical Outcome Assessment for AT & BCI
N/AHelp build intelligence for NeuralInk
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.